Colorectal cancer (CRC) is the second most common cause of death from cancer in the US and the most prevalent malignant tumor ...

Once the biomarkers were developed, the CNIO team tested them in an innovative way: with a simulated trial, that is, with ...

Cancer Research UK-funded scientists at the University of Cambridge create a test to predict resistance to chemotherapy. The test uses changes to cancer DNA at diagnosis to predict which patients will ...

Circulating tumor DNA (ctDNA) testing changes occur nearly every year, making consistent updates to National Comprehensive Cancer Network (NCCN) guidelines important for clinicians to make decisions ...

Johnnie J. Orozco, MD, PhD, a Fred Hutch hematologist-oncologist and assistant program director for the fellowship program, developed a grant-writing seminar for applicants covering best practices for ...

A new at-home self-collection device is taking aim at the screening gap for cervical cancer, and new research, ... screen," says Christine Conageski, MD, ... Clinical Validation of a Vaginal ...

CHICAGO — New study results show that a structured exercise program following surgery and adjuvant chemotherapy reduced the risk of recurrent or new cancer and increased survival for patients with ...

Huntsman Cancer Institute and University of Utah Health are pleased to announce the appointment of T. Clark Gamblin, MD, MS, MBA, FACS, as the inaugural chief of the Division of Surgical Oncology in ...

In addition, she has been a subinvestigator on hundreds of phases 1 and 2 antitumor clinical trials. She incorporates translational science into clinical trial designs by working with bench science ...

Key Facts. Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible.

Christine Kay, MD: I'm happy to be here at ARVO in Salt Lake City 2025 presenting on behalf of 4D Molecular Therapeutics (4DMT), the PRISM trial, which is a phase 1/2 clinical trial looking at a gene ...